Politico reports that Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary, MD, MPH, are at odds on how ...
The overall dry AMD market size in the US is anticipated to increase, due to the uptake of recently approved therapies, the launch of emerging therapies such as Gildeuretinol (Alkeus Pharmaceuticals), ...
Cadmus C. Rich, MD, MBA, as Chief Medical Officer, and Carlos Quezada-Ruiz, MD, FASRS, as Chair of the Scientific Advisory ...
A smart eye‑health plan starts with food and sunlight habits, then adds targeted supplements where evidence is strongest.
Company to present 40-week topline results from the Phase 2 study of migaldendranib (MGB), a first-in-class subcutaneous nanomedicine, being developed for the treatment of DME and nAMD FDA alignment ...